Filter News
Area of Research
- (-) Biology and Environment (42)
- (-) National Security (48)
- (-) Neutron Science (23)
- Advanced Manufacturing (2)
- Biological Systems (1)
- Biology and Soft Matter (1)
- Clean Energy (55)
- Computational Biology (2)
- Computational Engineering (2)
- Computer Science (6)
- Electricity and Smart Grid (1)
- Fuel Cycle Science and Technology (1)
- Functional Materials for Energy (1)
- Fusion and Fission (6)
- Isotope Development and Production (1)
- Isotopes (10)
- Materials (27)
- Materials for Computing (5)
- Nuclear Science and Technology (12)
- Sensors and Controls (1)
- Supercomputing (59)
- Transportation Systems (1)
News Topics
- (-) Artificial Intelligence (26)
- (-) Biomedical (27)
- (-) Decarbonization (22)
- (-) Molten Salt (1)
- (-) National Security (35)
- (-) Security (13)
- (-) Space Exploration (3)
- 3-D Printing/Advanced Manufacturing (17)
- Advanced Reactors (3)
- Big Data (16)
- Bioenergy (51)
- Biology (76)
- Biotechnology (13)
- Buildings (3)
- Chemical Sciences (14)
- Clean Water (13)
- Climate Change (43)
- Composites (5)
- Computer Science (47)
- Coronavirus (20)
- Critical Materials (1)
- Cybersecurity (19)
- Energy Storage (14)
- Environment (99)
- Exascale Computing (5)
- Fossil Energy (1)
- Frontier (5)
- Fusion (2)
- Grid (9)
- High-Performance Computing (26)
- Hydropower (8)
- Isotopes (2)
- Machine Learning (21)
- Materials (26)
- Materials Science (29)
- Mathematics (3)
- Mercury (7)
- Microscopy (13)
- Nanotechnology (18)
- Net Zero (2)
- Neutron Science (99)
- Nuclear Energy (8)
- Partnerships (8)
- Physics (12)
- Polymers (3)
- Quantum Computing (1)
- Quantum Science (8)
- Renewable Energy (1)
- Simulation (14)
- Summit (16)
- Sustainable Energy (33)
- Transformational Challenge Reactor (1)
- Transportation (10)
Media Contacts
The Accelerating Therapeutics for Opportunities in Medicine , or ATOM, consortium today announced the U.S. Department of Energy’s Oak Ridge, Argonne and Brookhaven national laboratories are joining the consortium to further develop ATOM’s artificial intelligence, or AI-driven, drug discovery platform.
Scientists have found new, unexpected behaviors when SARS-CoV-2 – the virus that causes COVID-19 – encounters drugs known as inhibitors, which bind to certain components of the virus and block its ability to reproduce.
Twenty-seven ORNL researchers Zoomed into 11 middle schools across Tennessee during the annual Engineers Week in February. East Tennessee schools throughout Oak Ridge and Roane, Sevier, Blount and Loudon counties participated, with three West Tennessee schools joining in.
As Hurricane Dorian raged through the Bahamas, researchers at Oak Ridge National Laboratory worked around the clock to aid recovery efforts for one of the Caribbean’s worst storms ever.
Six scientists at the Department of Energy’s Oak Ridge National Laboratory were named Battelle Distinguished Inventors, in recognition of obtaining 14 or more patents during their careers at the lab.
Oak Ridge National Laboratory and collaborators have discovered that signaling molecules known to trigger symbiosis between plants and soil bacteria are also used by almost all fungi as chemical signals to communicate with each other.
Jeff Johnson, nonproliferation research and development integration manager for ORNL’s National Security Sciences Directorate, has been honored by the American Nuclear Society
Six ORNL scientists have been elected as fellows to the American Association for the Advancement of Science, or AAAS.
NellOne Therapeutics has licensed a drug delivery system from the Department of Energy’s Oak Ridge National Laboratory that is designed to transport therapeutics directly to cells infected by SARS-CoV-2, the virus causing COVID-19.
Scientists from Oak Ridge National Laboratory used high-performance computing to create protein models that helped reveal how the outer membrane is tethered to the cell membrane in certain bacteria.